- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.61 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, S. et al., Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell (2005)
- Release Date
- 2005-04-26
- Peptides
- Epidermal Growth Factor Receptor: A
Cetuximab Fab Light chain: B
Cetuximab Fab Heavy chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
D